Acetaminophen

Mechanism of action

Central COX inhibition (analgesic / antipyretic)

In plain language

Dials down pain and fever by blocking the same kind of chemical messengers ibuprofen does — but mainly inside the brain and spinal cord, rather than throughout the whole body.

View

ClinicalPlain language

How it works

Acetaminophen's precise mechanism has not been definitively established, but the leading model holds that it inhibits cyclooxygenase (COX-1/COX-2) activity predominantly within the central nervous system rather than in peripheral tissues, reducing synthesis of prostaglandins (notably PGE2) involved in nociceptive signaling and hypothalamic thermoregulation. This CNS-selective action contrasts with NSAIDs, which inhibit COX peripherally as well, explaining acetaminophen's lack of clinically meaningful anti-inflammatory, antiplatelet, or gastric-irritant effects. The resulting drop in central prostaglandin production dampens ascending pain signaling and resets the hypothalamic thermal set point, producing analgesia and antipyresis. Secondary proposed contributors include modulation of descending serotonergic pain-inhibitory pathways and, via the active metabolite AM404, endocannabinoid/TRPV1 signaling, though these are considered adjunctive to the central COX pathway.

Therapeutic applications

Indicated (OTC internal analgesic/antipyretic monograph) for the temporary relief of mild-to-moderate pain, including headache, muscular aches, backache, minor osteoarthritic pain, toothache, common cold symptoms, and premenstrual/menstrual cramps, and for temporary reduction of fever. Prescription intravenous formulations are additionally indicated for management of mild-to-moderate pain, management of moderate-to-severe pain as an adjunct to opioid analgesics (to reduce opioid requirement), and reduction of fever, in adult and pediatric hospital settings.

Class

Small molecule

Therapeutic area

Analgesic / Antipyretic

Source

PubChem CID 1983 ↗FDA label (DailyMed) ↗